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SUMMARY 
 
This paper describes the development and validation 
of a new methodology for assessing the deleterious 
effects of spaceflight on crew health and perform-
ance. It is well known that microgravity results in 
various physiological alterations, e.g., headward 
fluid shifts which can impede physiological adap-
tation. Other factors that may affect crew opera-
tional efficiency include disruption of sleep-wake 
cycles, high workload, isolation, confinement, stress 
and fatigue. From an operational perspective, it is 
difficult to predict which individuals will be most or 
least affected in this unique environment given that 
most astronauts are first-time flyers. During future 
lunar and Mars missions space crews will include 
both men and women of multi-national origins, 
different professional backgrounds, and various 
states of physical condition. Therefore, new 
methods or technologies are needed to monitor and 
predict astronaut performance and health, and to 
evaluate the effects of various countermeasures on 
crew during long duration missions. This paper 
reviews several studies conducted in both laboratory 
and operational environments with men and women 
ranging in age between 18 to 50 years. The studies 
included the following: soldiers performing 
command and control functions during mobile oper-
ations in enclosed armored vehicles; subjects parti-
cipating in laboratory tests of an anti-motion 
sickness medication; subjects exposed to chronic 
hypergravity aboard a centrifuge, and subject 
responses to 36-hours of sleep deprivation. Physio-
logical measurements, performance metrics, and 
subjective self-reports were collected in each study. 
The results demonstrate that multivariate converging 
indicators provide a significantly more reliable 
method for assessing environmental effects on 
performance and health than any single indicator. 
 
 
STATEMENT OF THE PROBLEM 
 
This paper describes the development and validation 
of a new methodology for assessing the deleterious 
effects of spaceflight on crew health and perfor-
mance. In space, the absence of gravity alone causes 
unique physiological stress. Significant biomedical 
changes have been reported across multiple organ 
systems such as body fluid redistribution, dimin-
ished musculoskeletal strength, changes in cardiac 
function, and sensorimotor control and spatial 
perception (ref. 1). The time course of development 
of these disorders and the severity of symptoms 
experienced by individuals varies widely. Added to 
our knowledge of these micro-g effects on physiol-
ogy and potential negative impacts on crew opera-
tional efficiency, is the body of research on behav-
ioral effects of isolation, fatigue, workload (ref. 2); 
adverse environmental conditions (e.g., noise, 
vibration, extremes in temperature) and psycho-
social or interpersonal conflicts. People vary con-
siderably in their abilities to tolerate stress and 
function effectively. Future space crews will include 
both men and women of different cultures, different 
professional backgrounds, and various levels of 
physical conditioning. Consequently, it will be 
necessary to develop technologies which examine 
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unique characteristics of individuals in extreme 
environments, the effects on crew operational effi-
ciency, and effective interventions for counteracting 
adverse effects. 
 
The broad objective of our research program is to 
study individual characteristics of human adaptation 
or functional state. The term “functional state” is 
defined as the physiological and psychological state 
during which performance is highest (refs. 3-5). To 
achieve this goal, investigators have developed 
protocols designed to accurately assess and predict 
spaceflight effects on crew health, safety, and opera-
tional performance. Once identified, protocols may 
also be used to evaluate and test countermeasures 
that will correct adverse reactions. 
 
The National Aeronautics and Space Administra-
tion’s (NASA’s) human space program is currently 
using cognition metrics as the primary method for 
self-assessing environmental and interpersonal 
effects on crew functional state or behavioral health 
(refs. 6–8). There are only two cognitive test batter-
ies in use aboard the International Space Station 
(ISS); Spaceflight Cognitive Assessment Tool for 
Windows (WinSCAT) (refs. 9, 10) and MiniCog 
(ref. 11). The purpose of these test batteries is to 
allow comparison of preflight baseline performance 
of astronauts to that observed prior to high-risk 
activities during flight (e.g., EVA, docking; during 
periods of heavy workload; during sleep/circadian 
shifting; and whenever a crewmember desires a self-
assessment). These tools are intended to provide an 
early warning alert to indicate when an astronaut is 
suffering from stress-related deficits, such as high 
workload, that may affect performance. They can 
use the information alone or as part of a team. Users 
can be warned to pay additional attention and take 
extra care, take a break, consume food or caffeine, 
or even take a nap. As a medical tool, it could also 
be used following adverse events to evaluate the 
cognitive effects of head trauma, toxic exposure, 
and side effects of various medications. 
 
A potentially serious flaw identified for both of 
these cognitive assessment tools is the “ceiling 
effect,” in which performance metrics may peak at 
the same asymptotic level. This may ultimately 
result in severely reduced effectiveness for assessing 
prodromal or sub-clinical spaceflight effects on 
functional state. The ceiling effect occurs when 
subjects achieve a perfect score (100% correct) on 
subtests in these batteries, in which the number of 
total subtest presentations is constant. Performance 
ceilings are undesirable because there is no dis-
crimination measurable between subjects at the 
ceiling level (ref. 12). Often, performance tests will 
reveal this defect through a gradual reduction in 
between-subject variance (refs. 13, 14) where the 
data include ceiling scores. This means that reduced 
performance variance near the ceiling levels will be 
an unreliable estimate of population performance 
variability. These tests may show effects of severe 
trauma but not be sufficiently sensitive to assess or 
predict changes in operational efficiency and subse-
quent impacts on crew health and safety. 
 
Self-report scales, diaries, and post-flight debrief-
ings have been used routinely to evaluate physical 
symptoms, changes in mood, and interpersonal 
conflicts between crew members or crew and ground 
support personnel. With the exception of operational 
medicine procedures associated with screening 
candidates for selection as astronauts, and recom-
mended preflight psychosocial education training 
programs, NASA has devoted very little work to 
develop behavioral assessment tools and inter-
ventions that may be used inflight. Present knowl-
edge of the incidence and severity of abnormal 
behaviors during spaceflight has been obtained 
largely anecdotal. At a recent NSBRI workshop on 
cognition research in space (ref. 15), three concerns 
were identified as relevant to Behavioral Health 
Management: (a) Biomarkers—what are the objec-
tive physiological correlates of cognition? (b) Mod-
eling—what information is needed to develop 
predictors of impaired cognition? And (c) Crew 
Compliance—what can be done to assure crew use 
of these assessment tools? 
 
 
A NEW APPROACH—CONVERGING 
INDICATORS 
 
The underlying premise of this paper is that no 
single metric, cognitive test, physiological marker or 
subjective report, is sufficient when used alone to 
assess an individual crewmember’s functional state. 
A single indicator (e.g., subjective reports) may 
result in a false positive or negative assessment, 
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whereas multiple indicators enable cross-validation 
and account for individual variability. During cur-
rent ISS missions, in-flight physiological measures 
have been used primarily as a means of diagnosing 
and/or correcting biomedical problems associated 
with exposure to microgravity. There is a paucity of 
data available on the use of physiological measures 
as correlates of performance and behavioral states of 
crew in space. Although subjective reports have 
been standardized, with terms defined and numeric 
values assigned to “severity” of symptom or mood 
change experienced, these measures are less reliable 
since people differ in their ability to interpret, 
recognize, and willingness to report negative reac-
tions. Gender and cultural differences in the per-
ceived utility or value of these tools impact their 
efficacy and crew compliance. 
 
In the scientific and medical literature there is a 
considerable body of work that discusses psycho-
physiological measures of emotion, performance, 
workload, and other aspects of operator functional 
state (refs. 4, 16). A common methodology 
employed in many of these studies (refs. 17–20) is 
multiple converging indicators: physiological 
measures, subjective reports, and measures of overt 
behaviors. In studies of human emotion or affective 
states (ref. 21), measures of overt behaviors include 
expressive language, vocalization measures (ref. 22); 
voice stress measures (ref. 23), performance metrics 
(e.g., reaction time), and observable facial expres-
sions (ref. 24). Physiological responses add power to 
the evaluations by providing data that are not readily 
observable, yet are known to be reliable, objective 
indicators of emotion (central and peripheral 
nervous system; neuroendocrine function). 
 
NASA researchers have used ambulatory measures 
of autonomic responses in combination with per-
formance metrics and subjective self-reports to 
assess individual differences in functional state in 
laboratory studies (refs. 25–29) operational field 
tests (refs. 30, 31), during long and short duration 
space flight (refs. 32–37), and during studies of 
small group interactions (refs. 38–40). Other human 
factors researchers have extensively recorded meas-
ures of brain activity associated with fatigue and 
hazardous states of awareness within aviation envi-
ronments (ref. 41). 
 
This paper reviews the data of selected test partici-
pants from four studies where multiple converging 
indicators were used to assess individual differences 
in tolerance to environmental stressors. 
 
 
METHODS 
(Common to all studies described) 
 
Subjects 
Both men and women, ages 18 to 50, civilian and 
active duty military, participated in these studies. 
All research was approved by the NASA-Ames 
Human Research Institutional Review Board (and 
other institutional boards of specific collaborating 
agencies or universities) before tests were initiated. 
Voluntary informed consent was obtained in brief-
ings by the Principal Investigator and medical 
monitors. All subjects were medically approved for 
participation and excluded if they were pregnant, 
taking medication, had a chronic medical condition 
or histories of medical or mental disability. 
 
Physiological Measures 
An ambulatory physiological monitoring system was 
used in all studies. Measures recorded with this 
system included: (a) electrocardiograph; (b) respira-
tion; (c) finger pulse volume (peripheral vasomotor 
activity); (d) skin temperature; (e) skin conductance 
level and (f) a triaxial accelerometer (measuring 
head and upper body movement). Other non-
ambulatory measures included blood pressure and 
impedance cardiography. 
 
Performance Measures 
The Automated Portable Test System (APTS) 
cognitive performance test battery or its upgraded 
successor, DELTA, were used in these studies. Both 
batteries have been shown to have excellent stability 
and reliability (ref. 13), and exhibited no ceiling 
effects since the test software provided the opportu-
nity for subjects to achieve higher levels of perfor-
mance scores by increasing performance test speed 
(ref. 12). The APTS was developed with emphasis 
on within-subjects, repeated-measures designs, and 
has been proven both reliable and valid in a number 
of investigations, and administration takes approxi-
mately 15 minutes or less, depending upon the test 
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battery configuration. The DELTA test battery has 
been used extensively to study the effects of envi-
ronmental and chemical stressors on human per-
formance, and measures 67% of the aptitudes and 
abilities required to perform various real life space 
shuttle performance tasks (ref. 43), as analyzed by 
the Position Analysis Questionnaire (ref. 6). 
 
The sub-tests used in the studies described include 
(a) three-choice reaction time; (b) code substitution; 
(c) pattern comparison; (d) manual dexterity (pre-
ferred and nonpreferred hand tapping); (e) gram-
matical reasoning ability; and (f) spatial transforma-
tion (perceived position). Using the data from this 
performance battery, the level of impairment experi-
enced by subjects can be expressed as a Blood/ 
Alcohol Level Equivalency (BAL%). A detailed 
description of test methods is provided in another 
paper (refs. 31, 44). 
 
Self-Reports of Symptoms 
A computer program allowed the subject to rate 
his/her own symptoms using a standardized diagnos-
tic scoring procedure (table 1) referred to as the 
Coriolis Sickness Susceptibility Index, or CSSI 
(refs. 31, 45). The presence or absence and/or 
strength of symptoms were assessed subjectively by 
the subject (none “0”, mild "1,” moderate "2,” or 
severe "3"). These symptoms included drowsiness, 
sweating, salivation, pallor, and nausea. Other 
symptoms were scored as “none, mild or moderate” 
levels only. These included increased warmth, 
dizziness, and headache. Stomach awareness and 
discomfort (not nausea) are only rated as “mild.”  
 
Self-Reports of Mood and Sleep  
A 10-point Visual-Analog Scale (VAS) mood test 
was used to input responses to questions. The sub-
ject moved a cursor on a slide bar presented on his 
screen with the left/right arrow keys. There were 
descriptive adjectives at each end of the slide-bar, 
and the subject’s task was to position the cursor to 
enter his/her response (see table 2). A higher score 
for each mood state corresponds to a more favorable 
response. The test included eight mood scales and 
two sleep questions (ref. 46). The Active Mood 
Dimension reflects readiness to perform and 
includes a composite of fatigue level, arousal state, 
motivation to perform, and ease of concentration. 
The Affective Mood Dimension which reflects the 
subject’s perception of his readiness to perform 
included a composite of physical discomfort, 
elation, psychological tension, and contentedness. 
The “trouble falling asleep” question was scored 
from “much worse” (score = 0) to “much better” 
(score = 10), relative to the sleep quality during the 
previous night. The other sleep quality scale 
reported the number of times the subject woke up 
during the previous night. 
 
 
TABLE 1. SYMPTOM DIAGNOSTIC SCALE 
Severity Level none mild moderate severe 
 0 1 2 3 
Are you feeling warmer?    * 
Do you have any dizziness?    * 
Do you have a headache?    * 
Are you drowsy?     
Are you salivating more?     
Do you have facial pallor?     
Are you sweating?     
Do you feel stomach awareness?   * * 
Do you have stomach discomfort?   * * 
Do you have any nausea?     
Have you vomited today? yes____ no_____ 
If yes, how often?  
* indicate the severity level does not apply to these symptoms 
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TABLE 2. MOOD/SLEEP SCALE 
Mood State Response Scale 
Motivation Bored (0) ------------------------Interested (10) 
Arousal state Sleepy (0) ------------------------Alert (10) 
Fatigue level Weary (0) ------------------------Energetic  (10) 
Ease of concentration Very low (0) ------------------------Very high (10) 
Psychological tension Tense (0) ------------------------Relaxed (10) 
Elation Sad (0) ------------------------Happy (10) 
Physical discomfort Very high (0) ------------------------Very low (10) 
Contentedness Unpleasant (0) ------------------------Pleasant (10) 
Trouble falling asleep  Much worse (0) ------------------------Much better (10) 
How many times did you wake up last night? (0–6)? Amount___________ 
 
 
STUDY 1: 
Effects of Command and Control Vehicle 
(C2V) Operational Environment on Soldier 
Health and Performance 
 
A demonstration of the practical application of the 
converging indicator methodology under operational 
conditions occurred during a study performed in 
collaboration with the U.S. Army (ref. 31). The 
purpose of the study was to evaluate the effects of 
mobile operations on soldier health and performance 
in the Command and Control Vehicle (C2V, an 
armored tracked vehicle containing four computer 
workstations). The planned use for the C2V was to 
enable command decisions to be made in the field 
under combat conditions. However, there was a 
concern that soldiers might experience motion 
sickness symptoms that could impact their ability to 
carry out their mission objectives. 
 
In this study, there were three vehicles with different 
interior configurations: (a) all seats facing forward, 
(b) all seats perpendicular to the direction of travel, 
and (c) three seats set at 45 degrees from the front 
with one seat facing forward. The primary objective 
was to determine if motion sickness occurred and if 
so, under what operational conditions. Other objec-
tives were to determine if seat position or orienta-
tion was related to severity of symptoms, and what 
percentage of soldiers showed degradations in 
performance, health, or mood. Twenty-four soldiers 
(16 men and 8 women) participated, with each 
person riding in the C2V during 4-hour operational 
tests over a varied terrain. Each participant rode 12 
times, once in each seat of each vehicle. Prior to 
these field tests, all participants received classroom 
instructions on the PC-based performance test 
battery, symptom and mood scales. Physiological, 
performance, mood and symptom data were col-
lected during field tests. 
 
Results 
Detailed results of this study are reported in another 
paper (ref. 31). In summary, the results obtained 
were sufficient to answer the questions posed by the 
Army, and to successfully validate the assessment 
methods developed by NASA, thereby accom-
plishing important goals for both federal agencies. 
The preponderance of evidence provided by multi-
ple converging indicators used in this study have led 
to the following conclusions: (a) there was no 
significant difference between vehicle config-
urations; (b) there was negative impact on crew 
performance and health when subjects attended to 
visual computer screens while the vehicle was 
moving; (c) the severity of symptoms and perfor-
mance degradation were not substantially reduced 
by intermittent short-halts, and (d) performance and 
mood were impaired in the vehicle during the park 
condition, relative to pre- and post tests conducted 
in a classroom facility. 
 
The performance scores of test participants, aver-
aged across all twelve field test exposures, are listed 
in table 3. The table shows mean test percentages 
relative to classroom training (left) and these scores 
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converted to BAL% scores (right). Subjects are 
ranked from best performance to worst (BAL% > 
0.85 is the legal limit for automobile operators in 
most states). 
 
By comparing the three subjects with the highest 
performance scores and three with the lowest per-
formance scores, we can see how the converging 
indicator method can be used to describe individual 
differences. Subjects 12, 17, and 4 had good per-
formance scores, while subjects 22, 14, and 16 had 
poor performance. 
 
Figure 1 shows the performance scores and self-
reported mood and symptoms experienced by six 
subjects during one 4-hour field test in the C2V. The 
degree of performance impairment in general (com-
posite) and for each specific sub-test is shown as 
calculated BAL% scores across conditions of the 
field test (P = parked, M = moving, S = short halt or 
stationary). With no ceiling effect, Delta tests allow 
comparison of skill levels across subjects, enabling 
a determination of which subject might be best 
capable of performing specific tasks at any given 
time. For example, all three “good performers” 
showed composite scores lower than 0.08 BAL% 
(double horizontal line), but subject 17 showed 
more impairment on pattern recognition than either 
subjects 12 or 4. Because this specific sub-test is 
relevant to a needed mission skill, in this case map 
or radar reading, a decision could be made to not 
assign this task to subject 17 if the other subjects are 
available. Similarly, although all of the “poor per-
formers” showed composite scores well above the 
0.08 level, subject 22 would be better prepared to 
perform pattern recognition tasks more accurately 
than either subjects 14 or 16. 
 
 
 
TABLE 3. INDIVIDUALS RANKED BY PERCENT PERFORMANCE CHANGES AND BAL% 
SUBTEST MEAN PERCENTAGES    BAL% EQUIVALENCE 
Subject Park Move S-halt    Subject Park Move S-halt 
4 9.61 0.45 3.85    4 0.000 0.000 0.000 
12 8.73 6.99 3.93    12 0.000 0.000 0.000 
19 10.42 4.84 7.66    19 0.000 0.000 0.000 
17 1.28 –0.79 2.46    17 0.000 0.008 0.000 
11 5.21 –3.03 1.95    11 0.000 0.031 0.000 
2 3.49 –3.52 3.76    2 0.000 0.036 0.000 
5 –0.60 –3.69 –3.71    5 0.006 0.038 0.038 
8 –5.20 –4.06 –1.98    8 0.052 0.041 0.020 
1 3.86 –5.08 –5.31    1 0.000 0.051 0.053 
18 –3.29 –5.19 –5.74    18 0.034 0.052 0.055 
9 –3.01 –5.32 –2.94    9 0.031 0.053 0.030 
21 2.41 –6.97 –3.69    21 0.000 0.062 0.038 
10 –2.88 –8.51 –6.18    10 0.029 0.071 0.058 
20 –0.62 –8.81 0.52    20 0.006 0.073 0.000 
6 5.87 –8.86 –8.53    6 0.000 0.073 0.071 
15 –4.29 –10.53 –5.36    15 0.044 0.083 0.053 
13 0.32 –11.66 –4.53    13 0.000 0.089 0.046 
3 1.85 –11.98 –6.73    3 0.000 0.091 0.061 
24 –5.74 –15.39 –10.54    24 0.055 0.111 0.083 
23 –6.00 –15.64 –18.08    23 0.057 0.113 0.127 
22 –10.13 –17.70 –11.33    22 0.081 0.124 0.088 
14 –15.80 –20.89 –11.98    14 0.113 0.143 0.091 
16 –20.43 –32.62 –25.24    16 0.140 0.211 0.168 
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Self reports of mood and symptoms experienced for 
good and poor performers are graphed below their 
performance test scores. Mood scores are shown on 
the left axis (double horizontal line at 5 indicates 
“normal” mood for each subject), and total symp-
toms are on the right axis of each graph (dark hori-
zontal line at 8 symptoms indicates severe malaise 
level). Self reports are, by definition, “subjective” 
and these graphs show how reliable such reports are 
as indicators of each individual’s ability to perform 
specific tasks. For the “good performers” both 
subjects 12 and 14 are showing mood scores (readi-
ness to perform and self-perception of readiness) 
near to their own normal levels. Similarly, both of 
these subjects reported very low levels of malaise. 
Subject 17, however, began to experience severe 
malaise toward the middle of the field test (symptom 
scores higher than 8), with a corresponding decline 
in mood scores which preceded symptom reports. 
Among poor performers, subject 22 showed no 
decline in mood yet symptoms experienced tended 
to wax and wane across the field test. Subject 16 
experienced severe malaise throughout the 4-hour 
field test with a corresponding degradation of mood. 
Subject 14, however, reported no symptoms at all, 
even though mood scores for both readiness to 
perform and perceived readiness showed degrada-
tion from the norm. 
 
Figure 2 shows the physiological responses of all six 
subjects during the same field tests in which their 
performance, mood, and symptoms were recorded. 
The graph on the left shows (top to bottom) heart 
rate, skin conductance, and skin temperature of 
subjects with good performance scores, and the right 
side of this figure shows corresponding measures for 
the poor performers. Although performance tests 
and self-reports were administered only 6 times 
during field tests, physiological data were recorded 
continuously and are displayed as one-minute means 
across conditions (P = park, M1 = first movement, 
S1 = first stationary condition, etc.). Good perform-
ers produced less variability in response levels for  
 
skin conductance and skin temperature than did the 
poor performers. Further, subject 14, who reported 
no symptoms but showed degraded performance, 
produced higher heart rate and skin conductance 
with greater variability than the other subjects. 
These physiological levels are indicative of higher 
stress and are consistent with observed poor per-
formance of this subject. 
 
Previous research (refs. 25, 26, 28, 29) has shown 
that it is optimal to record at least four physiological 
measures in order to determine individual stress 
profiles: heart rate, skin conductance, peripheral 
vasomotor activity, and respiration rate (not 
graphed). At least one or more of these parameters 
can be used to define an individual stress profile. 
 
 
STUDY 2: 
Promethazine as a Motion Sickness 
Treatment: Impact on Human Performance 
and Mood States 
 
Intramuscular (IM) injections of promethazine in 
25 mg or 50 mg dosages are commonly used to treat 
space motion sickness in astronauts. A recent study 
examined the effects of IM. injections of prometha-
zine on performance, mood states, and motion sick-
ness in humans (refs. 47, 48). Twelve men, mean 
age 36 ±3.1, participated in one training day and 
three treatment conditions: a 25-mg injection of pro-
methazine, a 50-mg injection of promethazine, and a 
placebo injection of sterile saline. Each condition, 
scheduled at 7-day intervals, required an 8–10 hr 
day in which subjects were tested on 12 perform-
ance tasks, and were given a rotating chair motion 
sickness test. On the training day subjects were 
trained on each task to establish stability and profi-
ciency. Treatment conditions were counterbalanced 
and a double-blind procedure was used to administer 
the medication or placebo. 
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Figure 2. Physiological responses of good and poor performers during a C2V field test. 
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Results 
Table 4 shows the average BAL% scores of each 
subject recorded at 1 and 4 hours following IM 
injections of promethazine doses of 25 mg and 
50 mg. Analyses of group data found that statisti-
cally significant decrements in performance were 
observed for both dosages of promethazine as com-
pared to the placebo. Performance decrements were 
associated with mean blood alcohol equivalency 
levels of 0.085% for 25-mg and 0.137% for 50-mg 
doses. Mood scale results showed significant 
changes in individual subjective experiences with 
maximum deterioration in the arousal state and 
fatigue level. Only the 25-mg dosage significantly 
increased motion sickness tolerance when compared 
to the placebo. These data suggest that the effective 
doses of promethazine currently used to counteract 
motion sickness in astronauts may significantly 
impair task components of their operational per-
formance. 
 
TABLE 4. INDIVIDUAL BAL% FOLLOWING 
PROMETHAZINE INJECTIONS 
 25 mg 50 mg 
Subject 1 hr 4 hr 1 hr 4 hr 
1 0.015 0.022 0.076 0.034 
2 0.004 0.027 0.063 0.078 
3 0.243 0.270 0.429 0.418 
6 0.086 0.088 0.093 0.081 
8 0.014 0.029 0.288 0.281 
9 0.000 0.196 0.000 0.133 
10 0.129 0.122 0.086 0.080 
11 0.032 0.062 0.091 0.040 
12 0.107 0.045 0.128 0.031 
13 0.133 0.129 0.212 0.174 
14 0.125 0.111 0.110 0.082 
15 0.050 0.121 0.044 0.017 
Mean = 0.085 0.105 0.137 0.128 
 
The present paper examines individual differences 
in converging indicators of two subjects who were 
good performers (subjects 1 and 11) and two poor 
performers (subjects 3 and 13). Figure 3 shows the 
performance scores and self-reported mood experi-
enced by these subjects across the test conditions 
(different days) of placebo, 25-, and 50-mg doses. 
The top left graph shows the BAL% of two good 
performers and top right shows poor performers. 
Note that the horizontal lines at 0.08 on top left and 
right charts indicate that levels above this line 
represent performance impairment. 
 
The first performance battery of each day was 
administered before subjects received an injection 
and therefore results are near or below the 0.08 
BAL%. The next performance test was administered 
within one hour of the IM injections; the remaining 
task batteries followed at 2, 4 and 6 hours respec-
tively. The last delta performance battery was con-
ducted at the end of the day and was preceded by a 
rotating chair motion sickness test. The graphs show 
that performance scores begin to return to normal 
baseline levels as the medication wears off at hour 
6. In fact, changes in performance of these subjects 
closely mirror their serum dose-response curves. 
The bottom left chart shows the mood reports of 
good performers and the bottom right shows poor 
performers. In all cases, readiness to perform was 
degraded more than perceived readiness. This is 
more pronounced for subject 13 who showed the 
largest discrepancy for these self-reported mood 
states. 
 
These data clearly demonstrate that cognitive tests 
like Delta can be used to track the negative effects 
of this medication on an individual’s performance 
over time. Crews in space could use these tests to 
determine which of its members might be “best fit” 
to perform specific mission critical tasks and how an 
individual’s fitness to perform may be degraded or 
improved by any given countermeasure. 
 
Individual differences in physiological responses to 
this medication may help elucidate how and why 
subjects respond as they do. The overall group effect 
was that promethazine, an anticholinergic, sup-
pressed the skin conductance level (SCL) response 
(refs. 47, 48). SCL is only innervated by sympathe-
tic pathways and is therefore a good index of arousal 
(i.e., sympathetic activation); however, the 
transmitter substance for this response is choliner-
gic. Figures 4 and 5 show the physiological 
responses measured during Delta performance tests 
for good and poor performers respectively. What is 
immediately apparent from these charts is that no 
two people respond in precisely the same way. To 
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Figure 4. Physiological responses of subjects with good performance when given promethazine. 
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Figure 5. Physiological responses of subjects with poor performance when given promethazine. 
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evaluate the relationship between performance and 
physiology, emphasis should be placed on examin-
ing subject differences, rather than between sub-
jects. In general, when a subject’s performance was 
better (i.e., placebo day), his physiological 
responses were different than on those days when 
medication was given and performance was 
impaired. Psychophysiological research has demon-
strated that an individual physiological stress profile 
can be determined that will allow assessment and 
potential prediction of performance. Further, this 
research supports the assertion that responses to 
environmental stressors are highly idiosyncratic and 
therefore countermeasures must be tailored to meet 
an individual’s needs. 
 
Figure 6 shows changes in motion sickness toler-
ance during rotating chair tests administered before 
the final delta test battery on each day, at approxi-
mately 4 hours post-injection. Of the two good 
performers, only subject 11 showed an appreciable 
increase in motion sickness tolerance when given 
the 25 mg dose of promethazine. There was no 
change observed with the 50 mg dose. When admin-
istering this, or any countermeasure, consideration 
must be given to the “risks versus benefits.” The 
performance of subjects 1 and 11 were not degraded 
by this medication, but only subject 11 showed an 
observable increase in his motion sickness tolerance. 
This leads to the conclusion that the benefit to 
subject 11 was worth the “risk,” but there was no 
benefit to subject 1 and therefore he should not be 
medicated. Of the two subjects whose performance 
was severely degraded by this medication, there 
were smaller improvements in motion sickness 
tolerance (50-mg dose for subject 3 and 25-mg dose 
for subject 13). Therefore, there was a greater risk 
that performance would be degraded compared to 
the relatively small benefit of an anti-motion sick-
ness medication. 
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STUDY 3: 
Individual Differences in Adaptational 
Capacity During Sustained Exposure to 
Hypergravity 
 
The purpose of this study was to determine if 
22-hour exposures to sustained hypergravity in a 
centrifuge would improve g-tolerance of individuals. 
Four men, ages 20–34 years old, participated in this 
study. The present paper discusses the data of two 
subjects with the highest and lowest g-tolerance. 
G-tolerance tests were conducted before and after 
each 22-hour centrifuge run. During g-tolerance 
tests subjects were seated upright with the gravity 
vector oriented from chest to back (Gz) while the 
centrifuge was rotating. Tests were terminated when 
subjects reported a significant loss of peripheral 
vision, commonly referred to as gray-out. Physio-
logical measurements provided a means of evaluat-
ing individual differences in g-tolerance and the 
individual’s capacity to adapt to this environmental 
stressor. In addition to the four standard ambulatory 
measures of heart rate, skin conductance level, 
respiration rate and peripheral vasomotor activity, 
other measures of cardiovascular function, mean 
arterial pressure and impedance cardiography, were 
recorded. These parameters provided continuous 
measurements of cardiac output, stroke volume and 
total peripheral resistance. In space, these measure-
ments are obtained using echocardiography, which 
can only provide a static “snap-shot” of a crew-
members cardiac function, and it requires a highly 
trained technician. 
 
Figure 7 shows the physiological responses of these 
subjects during one g-tolerance test. The left Y-axis 
shows beats per minute for heart rate and mmHg for 
mean arterial pressure. The right Y-axis shows Gz 
(g-level) liters per minute for cardiac output and 
liters (converted from ml) for stroke volume. The 
X-axis shows elapsed time. Subject 20 (top graph) 
was able to tolerate 6.29 g before terminating the 
test, while subject 23 (bottom graph) had lower 
g-tolerance, stopping at 3.91 g. Both subjects were 
well within the normal range of g-tolerance for men 
of their age and health. 
 
Both subjects responded to the increased g-load with 
compensatory increases in cardiac output and mean 
arterial pressure. However, the way in which the 
subjects achieved compensation was different. 
Subject 20 (high-g tolerance) experienced an 
increase in heart rate which was greater than his 
increase in stroke volume. Subject 23, however, had 
a greater increase in stroke volume (contractility of 
the myocardium) relative to his increase in heart 
rate. In the Earth norm of 1 g, these responses serve 
as an example of how the level of cardiovascular 
conditioning will affect an individual’s response to 
increased metabolic demands (environmental stress-
sors). The more physically fit individual will likely 
show a compensatory mechanism that favors a 
greater increase in stroke volume relative to a low 
(resting) heart rate because the myocardium is better 
adapted to producing a greater ejection fraction. 
This also means that there is less of a decrease in 
diastole and therefore greater ventricular and coro-
nary artery filling times. This enables such a person 
to have a greater reserve in his or her cardiac output. 
 
But what happens in an unusual environment, where 
there is an altered gravitational load than normally 
experienced? Subject 20 with labile, larger magni-
tude physiological response levels, where heart rate 
and cardiac output began to increase prior to the 
onset of the Gz stimulus (anticipatory responses) 
showed better tolerance than the more athletic 
subject 23. 
 
After determining differences between these indivi-
duals in tolerating an “acute” stress of a g-tolerance 
test, we examined their abilities to adapt to a 
“chronic” stress of sustained exposure to altered 
gravity. Ambulatory subjects were tested individu-
ally during chronic 22-hour exposures to constant 
gravitational loads: 1.0, 1.25, and 1.5 g, with 7-day 
intervals between exposures. Subjects were housed 
within a habitat cab (dimensions: 6 ft wide x 8 ft 
deep x 7 ft high) at the end of a long-arm centrifuge. 
The habitat cab contained a bed, a collapsible toilet, 
storage areas for food and water, a television set, 
and a laptop computer. Physiological responses 
were measured continuously and the subjects were 
monitored by close-circuit television with two-way 
voice communication. 
  16
Subject 20  High G Tolerance 
40
60
80
100
120
140
160
180
200
0:15 0:30 0:45 1:00 1:15 1:30 1:45 2:00 2:15 2:30 2:45 3:00 3:15 3:30
elapsed time in minutes
be
at
s 
pe
r m
in
ut
e 
/ m
m
Hg
 / 
m
l 
0
2
4
6
8
10
12
14
16
 li
te
rs
 p
er
 m
in
ut
e 
/ G
z
Heart Rate Mean Arterial Pressure
Stroke Volume Cardiac Output
Gz
 6.29 G
Subject 23 Low G Tolerance 
40
60
80
100
120
140
160
180
200
0:15 0:30 0:45 1:00 1:15 1:30 1:45 2:00 2:15 2:30 2:45 3:00 3:15 3:30
elapsed time in minutes
be
at
s 
pe
r m
in
ut
e 
/ m
m
Hg
 / 
m
l
0
2
4
6
8
10
12
14
16
lit
er
s 
pe
r m
in
 / 
G
z
3.91 G
 
Figure 7. Physiological response of subjects with high and low g tolerance. 
 
  17
At 4-hour intervals throughout chronic exposures, 
subjects self-administered a mood test, symptom 
diagnostic report, and the Delta performance battery 
(spatial perception, grammatical reasoning and 
manual dexterity) using their laptop computers. 
Then, changes in their orthostatic tolerance were 
examined during a stand test where the subject was 
supine, sitting and standing for 3-min in each posi-
tion. The result of this study was that subject 20, 
who tolerated a higher g-load during chronic tests, 
was also able to complete chronic 22-hr exposures 
to 1.25 and 1.5 g, while subject 23 experienced 
vasovagal syncope after 16 hours at 1.25 g. Figure 8 
shows a detail of these subjects’ physiological 
responses during stand tests after 16 hours at 1.25 g. 
In the upper graphs, the Y-axis on the left shows 
beats per minute (heart rate) and mmHg (blood 
pressure), the Y-axis on the right shows liters per 
minute (cardiac out put) and liters (converted from 
ml) for stroke volume. The lower graphs show each 
subject’s heart rate relative to changes in his tho-
racic fluid volume (also derived from impedance 
cardiography) that occur as the subject shifts posi-
tion. The cardiovascular dynamics show how these 
subjects compensated differently for thoracic fluid 
shifts. 
 
Subject 20 (good g-tolerance) makes the adjustment 
from supine to sitting and to standing with compen-
satory increases in heart rate during each shift of 
position. Heart rate is lower for Subject 23 (vaga-
tonic profile), and despite increased stroke volume, 
he experiences orthostatic intolerance. The more 
labile responses of subject 20 (sympathetic profile) 
may have protected him from orthostatic intolerance 
but made him more susceptible to motion sickness 
experienced during 1.5-g confinement for 22 hours. 
 
Figure 9 shows the performance, mood and symp-
tom reports of these subjects while in the centrifuge 
habitat. BAL% scores were not calculated because 
of an insufficient number of sub-tests. Raw data 
were converted to accuracy scores (number correct 
minus number wrong) for spatial perception and 
grammatical reasoning and for manual dexterity, the 
number of finger taps made with the non-preferred 
hand. Accuracy scores for subject 20 on both spatial 
perception and grammatical reasoning tasks 
decreased during 1.25-g and 1.5-g conditions 
relative to 1.0 g, while there was no notable change 
for the manual dexterity task across conditions. 
Subject 23’s scores on both spatial perception and 
grammatical reasoning were lower than for subject 
20, while there were no changes across conditions. 
Self reports mood show a small decline across 
g-load conditions for subject 20 with increased 
reports of malaise, resulting in vomiting during 
1.5 g. Subject 23 showed no discernable changes in 
mood and very mild malaise, even in tests conducted 
just prior to syncope at 1.25 g. 
 
 
STUDY 4: 
Individual Differences in Response to 
Sleep Deprivation 
 
In this study, test participants were subjected to 36 
hours of sleep deprivation. Physiological responses 
were measured continuously and performance tests 
and self report scales (mood and symptoms) were 
administered at 3 hour intervals. Three subjects are 
described in this study (2 men and 1 woman, ages 
25–35). All subjects were given 8 training sessions 
(15-min. each) distributed over two days before the 
start of sleep deprivation to establish a learning 
plateau. Twenty-four hours following sleep depriva-
tion when subjects were rested and recovered, an 
additional post-test task battery was administered. 
and data were detrended for practice effects. Figure 
10 shows the blood alcohol equivalencies calculated 
for these subjects. 
 
Figure 11 shows a comparison of specific Delta 
subtests to comparable tests within Minicog and 
Winscat. Delta tests show scores for accuracy 
(number correct minus the number of wrong 
answers) and both Mini cog and Winscat are shown 
as percent correct. The ceiling effect of Winscat and 
Minicog is demonstrated when scores equal 100% 
correct. The ceiling effect is based on the fact that 
Winscat and Minicog have a fixed number of pre-
sentations whereas the Delta battery is based on a 
fixed subtest duration so that a subject may perform 
different numbers of presentations depending upon 
his performance speed. Subject 33 shows a perform-
ance decrement for Mental Rotation (MiniCog) and 
Code substitution (Winscat) that is related to 
duration of sleep deprivation. The Minicog data for 
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Figure 11. Comparison of Delta, Winscat, and Minicog during sleep deprivation. 
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Logical reasoning (middle graph) tells us nothing 
about absolute changes in this subtest for any of the 
subjects because most tests have reached the ceiling 
level, in which performance proficiencies above the 
ceiling level cannot be documented. The incidence 
of ceiling effects was similar between Minicog 
(22.6%) and Winscat (26.8%). 
 
 
DISCUSSION—CONCLUSIONS 
 
The intent of this paper was to describe in detail the 
methodology of coverging indicators and its applica-
tion for assessing performance effects in both labo-
ratory and operational environments. The four 
studies described demonstrate that objective physio-
logical measures, quantifiable performance metrics, 
and subjective self-report scales, can be used to 
characterize individual differences in operational 
efficiency, as well as an individual’s ability to adapt 
to extreme environments. These metrics can also be 
used to assess the beneficial effects or unwanted 
side effects of pharmacological or behavioral coun-
termeasures. By selecting subjects at the extreme 
range of good and poor performance, it was possible 
to show how the metrics co-vary across individuals.  
 
The time required to record, evaluate, and decide 
how to act on multiple metrics in an operational 
environment would appear to make it an impractical 
approach. A real-time operational assessment and 
prediction tool should be non-obtrusive, non-
invasive, and yet make use of multiple indicator data 
without requiring the operator to attend to and inter-
pret their meaning. Our own research suggests that 
physiological responses can be used to develop an 
individual profile that depicts how bodily responses 
change with operator state. If converging indicator 
data are collected during baseline (or preflight) 
conditions (e.g., mission simulations), a “stress pro-
file” can be calculated that reflects an individual’s 
performance readiness in operational environments 
on the basis of his or her own physiological changes. 
Crewmembers could then be trained to recognize 
their responses to stressful events with the aid of 
real-time physiological feedback. Alternatively, 
ambulatory physiological data could be used as 
input variables for a real-time neural network model 
(e.g., with a wearable PC) to automatically “warn” 
the operator of predicted state changes. The crew-
member can then verify the predicted state changes 
(e.g., perform Minicog or Winscat) and either 
reschedule or reassign tasks to another available 
crewmember, or initiate a countermeasure. A poten-
tially powerful behavioral countermeasure would 
involve training crewmembers to change their own 
physiological response levels to maintain perfor-
mance efficiency. 
 
Our research group first used the converging indi-
cators approach in earlier studies on assessment and 
treatment of motion sickness. In these studies 
(refs. 42, 48–52) the method involved measuring an 
individual’s physiological responses and self-reports 
of malaise as symptoms were elicited during a 
motion sickness test. Then a physiological training 
program, referred to as Autogenic-Feedback 
Training Exercise (AFTE), was introduced. The 
training goal for subjects was to mimic their own 
resting physiological response levels during subse-
quent motion tests, and thereby significantly reduce 
or eliminate their symptoms. Following this logic, it 
was hypothesized that it would be possible to 
improve performance in stressful environments by 
monitoring changes in physiology, and training 
subjects to control their responses. One study per-
formed with Coast Guard Search and Rescue pilots 
was an operational demonstration of the effective-
ness of this approach (ref. 30). Pilots who were 
trained to monitor and regulate their own bodily 
responses demonstrated significant improvements 
on Federal Aviation Administration performance 
metrics compared to their untrained counterparts. 
These results indicate that such training may serve 
as a valuable adjunct to the current standard cockpit-
crew-resource management training. In the centri-
fuge study, it is possible that if subject 20 was 
trained to regulate his own heart rate, syncope might 
not have occurred. Subject 23, who experienced 
motion sickness, may have been able to control his 
symptoms with training. 
 
Because AFTE training involves both increasing and 
decreasing physiological response levels it should 
be applicable in a variety of situations. Fatigue 
related performance decrements caused by sleep loss 
or sustained operations might be improved if sub-
jects were trained to regulate their own responses 
including autonomic and central nervous system 
parameters. Enabling subjects to monitor, interpret, 
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and regulate their own cardiovascular dynamics 
could improve their orthostatic tolerance and health, 
thereby facilitating the successful completion of 
critical mission operations (refs. 36, 42). 
 
Converging indicators should be included in new 
research studies planned with crews on ISS. Ambu-
latory physiological monitors are unobtrusive, com-
fortable to wear, easy to operate, and are currently 
available through commercial vendors. Develop-
ment of sensors that do not require skin contact 
would improve crew comfort and compliance for 
self-monitoring and assessment. Baseline converg-
ing indicator data of individual crew could begin 
immediately and should be obtained prior to 
missions during simulations, physical exercise, and 
in aircraft. These data should be collected during 
screening for side-effects of medications. This infor-
mation should be used by the autonomous crew-
member in space to compare his own pre-flight data 
to his current physiological levels and performance 
metrics.  
 
Space flight analog studies are needed to further test 
countermeasure effects and other assessment tech-
niques that will be used by autonomous crews 
during future planned missions in space. Studies that 
compare cognitive assessment batteries like 
Winscat, Minicog, and Delta should be used to 
determine procedures for administering and scoring 
performance tests, without ceiling effects, and 
enable crews to decide which of their members is 
best fit (or when they themselves are ready) to per-
form specific mission tasks. Analog environments, 
with small groups, isolated in enclosed habitats and 
subject to environmental stressors, could be used to 
study and perfect assessment, training techniques, 
and countermeasures planned for future space 
crews. Such environments could include isolation 
studies (e.g., Antarctica, undersea labs) or opera-
tional military vehicles on land, sea or air. Analog 
crews, such as military officers, using these tools 
would go far to demonstrate their efficacy to the 
astronaut office, before they are flight tested on the 
International Space Station and in subsequent plane-
tary missions. 
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This paper describes the development and validation of a new methodology for assessing the deleterious effects of spaceflight on crew health and performance.
It is well known that microgravity results in various physiological alterations, e.g., headward fluid shifts which can impede physiological adaptation. Other
factors that may affect crew operational efficiency include disruption of sleep-wake cycles, high workload, isolation, confinement, stress and fatigue. From an
operational perspective, it is difficult to predict which individuals will be most or least affected in this unique environment given that most astronauts are first-
time flyers. During future lunar and Mars missions space crews will include both men and women of multi-national origins, different professional backgrounds,
and various states of physical condition. Therefore, new methods or technologies are needed to monitor and predict astronaut performance and health, and to
evaluate the effects of various countermeasures on crew during long duration missions. This paper reviews several studies conducted in both laboratory and
operational environments with men and women ranging in age between 18 to 50 years. The studies included the following: soldiers performing command and
control functions during mobile operations in enclosed armored vehicles; subjects participating in laboratory tests of an anti-motion sickness medication;
subjects exposed to chronic hypergravity aboard a centrifuge, and subject responses to 36-hours of sleep deprivation. Physiological measurements, perfor-
mance metrics, and subjective self-reports were collected in each study. The results demonstrate that multivariate converging indicators provide a significantly
more reliable method for assessing environmental effects on performance and health than any single indicator.
A-0600010
